Your browser doesn't support javascript.
loading
Homozygous FCGR3A-158F mutation is associated with delayed B-cell depletion following rituximab but with preserved efficacy in a patient with refractory lupus nephritis.
Seret, Guillaume; Hanrotel, Catherine; Bendaoud, Boutahar; Le Meur, Yannick; Renaudineau, Yves.
Afiliação
  • Seret G; EA2216 Immunology and Pathology, European University of Brittany, Brest, France; Laboratory of Immunology, Brest University Medical School, CHRU Morvan,Brest, France; Unit of Nephrology, Brest University Medical School, CHRU Cavale Blanche, Brest, France.
  • Hanrotel C; Unit of Nephrology , Brest University Medical School, CHRU Cavale Blanche , Brest , France.
  • Bendaoud B; EA2216 Immunology and Pathology, European University of Brittany, Brest, France; Laboratory of Immunology, Brest University Medical School, CHRU Morvan,Brest, France.
  • Le Meur Y; EA2216 Immunology and Pathology, European University of Brittany, Brest, France; Unit of Nephrology, Brest University Medical School, CHRU Cavale Blanche, Brest, France.
  • Renaudineau Y; EA2216 Immunology and Pathology, European University of Brittany, Brest, France; Laboratory of Immunology, Brest University Medical School, CHRU Morvan,Brest, France.
Clin Kidney J ; 6(1): 74-76, 2013 Feb.
Article em En | MEDLINE | ID: mdl-27818754
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2013 Tipo de documento: Article País de afiliação: França
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2013 Tipo de documento: Article País de afiliação: França